SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-18
👔
Sionna Therapeutics, Inc.
@SION_InsiderForm 4 Filing: Fitzpatrick Jennifer Acquires (Grant) shares of $SION
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Sionna Therapeutics, Inc.
Ticker: $SION
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-09-17
Shares: 56,265
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Fitzpatrick Jennifer, holds the title of CLO and Head of Program Mgmt. at Sionna Therapeutics, Inc..
On 2026-09-17, the insider transacted 56,265 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Fitzpatrick Jennifer (CLO and Head of Program Mgmt.) was granted $0 of $SION
Post-Transaction Position: 28,133 shares
SEC Accession No: 0002061851-26-000009 (CIK: 2061851)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.